Hospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2022

  1. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

2010

  1. Documento de consenso interdisciplinar para el tratamiento de la fibromialgia

    Actas Espanolas de Psiquiatria, Vol. 38, Núm. 2, pp. 108-120

2007

  1. Previous tumour as a prognostic factor in stage I non-small cell lung cancer

    Thorax, Vol. 62, Núm. 5, pp. 386-390

1999

  1. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: The EDICTA study

    Journal of Hypertension